Zeitschriftenartikel zum Thema „305.5/67/092 b“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "305.5/67/092 b" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Ferrari, Anna C., Yu-Hui Chen, Gary R. Hudes, Michael Anthony Carducci, Emmanuel S. Antonarakis, Noah M. Hahn, Yu-Ning Wong und Robert S. DiPaola. „E2809: Androgen receptor (AR) modulation by bicalutamide (Bic) and MK-2206 (MK) in men with rising PSA at high-risk of progression after local prostate cancer (PC) treatment.“ Journal of Clinical Oncology 34, Nr. 2_suppl (10.01.2016): 9. http://dx.doi.org/10.1200/jco.2016.34.2_suppl.9.
Der volle Inhalt der QuelleRomero, Samuel, Juan Montoro, Jaime Sanz, Marta Guinot, Empar Mayordomo, Rafael López, Isabel Beneyto et al. „Comparative Study of Post-Transplant Lymphoproliferative Disorders after Solid Organ Transplantation Versus Hematopoietic Stem Cell Transplantation“. Blood 126, Nr. 23 (03.12.2015): 4358. http://dx.doi.org/10.1182/blood.v126.23.4358.4358.
Der volle Inhalt der QuelleYan, Xiao J., Daniel Kalenscher, Erin Boyle, Sophia Yancopoulos, Rajendra N. Damle, Aarti Damle, Houman Khalili et al. „Gene Set Enrichment Analysis of Ki-67high CLL Clones Suggests Complex Interactions of B-Cell Receptor Signaling and Normal Cell Interactions in the Disease“. Blood 118, Nr. 21 (18.11.2011): 2833. http://dx.doi.org/10.1182/blood.v118.21.2833.2833.
Der volle Inhalt der QuelleAmisha, Fnu, Sunilkumar Kakadia und Akash Mukherjee. „Clinical Outcome of Refractory Lymphoma Patients with Non Response to Chimeric Antigen Receptor T Cell Therapy“. Blood 138, Supplement 1 (05.11.2021): 4823. http://dx.doi.org/10.1182/blood-2021-154356.
Der volle Inhalt der QuelleZahid, Anza, Prema P. Peethambaram, Carrie A. Thompson, Minetta C. Liu, Kathryn Jean Ruddy, Sushil s. Luis, Malcolm s. Anastasius et al. „Descriptive evaluation of frequent patient referrals to our cardio-oncology clinic: The Mayo experience.“ Journal of Clinical Oncology 38, Nr. 15_suppl (20.05.2020): e14018-e14018. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e14018.
Der volle Inhalt der QuelleDavids, Matthew Steven, Andrew Warwick Roberts, John Francis Seymour, William G. Wierda, Soham D. Puvvada, Lori A. Gressick, Debbie Alter et al. „Venetoclax (VEN) in patients with relapsed/refractory non-Hodgkin lymphoma (NHL).“ Journal of Clinical Oncology 35, Nr. 15_suppl (20.05.2017): e19041-e19041. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e19041.
Der volle Inhalt der QuelleMoccia, Moccia A., Jane Donaldson, Mukesh Chhanabhai, Paul Hoskins, Richard Klasa, Kerry J. Savage, Tamara Shenkier et al. „The International Prognostic Factor Project Score (IPS) in Advanced Stage Hodgkin Lymphoma Has Limited Utility in Patients Treated in the Modern Era.“ Blood 114, Nr. 22 (20.11.2009): 1554. http://dx.doi.org/10.1182/blood.v114.22.1554.1554.
Der volle Inhalt der QuelleIssa, Ghayas C., Hagop M. Kantarjian, C. Cameron Yin, Koji Sasaki, Guillermo Garcia-Manero, Courtney DiNardo, Koichi Takahashi et al. „Prognostic Implications of Pre-Treatment Hypodiploidy and Complex Cytogenetics in Adult Patients with Acute Lymphocytic Leukemia (ALL) Treated with Hyper-CVAD“. Blood 126, Nr. 23 (03.12.2015): 4874. http://dx.doi.org/10.1182/blood.v126.23.4874.4874.
Der volle Inhalt der QuelleRabaglio, Manuela, Daniel Dietrich, Bernhard Scheibe, Thomas Ruhstaller, Franco Nole, Serenella Eppenberger, Christian Oehlschlegel et al. „Abstract P4-01-25: Safety analysis after 11 years of follow-up of the randomized phase III trial SAKK22/99: upfront chemotherapy in advanced HER2 positive breast cancer“. Cancer Research 83, Nr. 5_Supplement (01.03.2023): P4–01–25—P4–01–25. http://dx.doi.org/10.1158/1538-7445.sabcs22-p4-01-25.
Der volle Inhalt der QuelleКвітіньйо Макарена Мартінез, Соріано Федеріко Ґонзало, Яйченко Вірджинія, Стіб Бренда und Барейро Хуан Пабло. „Predictors of Picture Naming and Picture Categorization in Spanish“. East European Journal of Psycholinguistics 6, Nr. 1 (30.06.2019): 6–18. http://dx.doi.org/10.29038/eejpl.2019.6.1.cui.
Der volle Inhalt der QuelleLykova, Inna, Ralph Rowe, Glenn Poirier, Henrik Friis und Kate Helwig. „Mckelveyite group minerals – Part 2: Alicewilsonite-(YCe), Na2Sr2YCe(CO3)6 ⋅ 3H2O, a new species“. European Journal of Mineralogy 35, Nr. 1 (28.02.2023): 143–55. http://dx.doi.org/10.5194/ejm-35-143-2023.
Der volle Inhalt der QuelleVarettoni, Marzia, Luca Arcaini, Silvia Zibellini, Emanuela Boveri, Sara Rattotti, Roberta Riboni, Alessandro Corso et al. „Prevalence and Clinical Significance of the MYD88 (L265P) Somatic Mutation in Patients with Waldenström Macroglobulinemia, IgM-Monoclonal Gammopathy of Undetermined Significance or Other Mature B-Cell Neoplasms.“ Blood 120, Nr. 21 (16.11.2012): 2667. http://dx.doi.org/10.1182/blood.v120.21.2667.2667.
Der volle Inhalt der QuelleCastillo, Jorge, Brady Beltran, Jaime Collins, Jose L. Diez-Martin, Francisco Hernandez-Ilizaliturri, Steven M. Horwitz und Julie M. Vose. „Clinicopathologic Characteristics of HIV-Associated Peripheral T-Cell Lymphoma.“ Blood 114, Nr. 22 (20.11.2009): 3924. http://dx.doi.org/10.1182/blood.v114.22.3924.3924.
Der volle Inhalt der QuelleYilmaz, Musa, Hagop M. Kantarjian, Jorge Cortes, Guillermo Garcia-Manero, Jad Chahoud, Farhad Ravandi, Koji Sasaki et al. „Results of Intensive Chemotherapy in 434 Adult Patients (pts) with Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL): Predictive Prognostic Model for Survival“. Blood 126, Nr. 23 (03.12.2015): 3722. http://dx.doi.org/10.1182/blood.v126.23.3722.3722.
Der volle Inhalt der QuelleScheid, Christof, Pieter Sonneveld, Ingo Schmidt-Wolf, Bronno van der Holt, Thomas Hielscher, Laila el Jarari, Uta Bertsch et al. „Influence of Renal Function on Outcome of VAD or Bortezomib, Doxorubicin, Dexamethasone (PAD) Induction Treatment Followed by High-Dose Melphalan (HDM): A Subgroup Analysis From the HOVON-65/GMMG-HD4 Randomized Phase III Trial for Newly Diagnosed Multiple Myeloma“. Blood 116, Nr. 21 (19.11.2010): 2396. http://dx.doi.org/10.1182/blood.v116.21.2396.2396.
Der volle Inhalt der QuelleSchönland, Stefan, Ute Hegenbart, Christoph Kimmich, Katarina Lisenko, Dirk Hose, Hartmut Goldschmidt, Anna Jauch, Anthony D. Ho und Michael Hundemer. „Detection and Characterization of Plasma Cell and B Cell Clones in Patients with Systemic Light Chain Amyloidosis Using Flow Cytometry“. Blood 124, Nr. 21 (06.12.2014): 2068. http://dx.doi.org/10.1182/blood.v124.21.2068.2068.
Der volle Inhalt der QuelleSaxton, Claire, Kirstin Fearnley, Maria B. Gonzalo und Cynthia Schwartz. „Abstract P3-17-01: Metastatic breast cancer caregiver participation in a psychoeducational cancer support program: Results from the frankly speaking about cancer: Metastatic breast cancer evidence-based educational workshops“. Cancer Research 82, Nr. 4_Supplement (15.02.2022): P3–17–01—P3–17–01. http://dx.doi.org/10.1158/1538-7445.sabcs21-p3-17-01.
Der volle Inhalt der QuelleAndreica, I., I. Roman, X. Baraliakos, U. Kiltz und J. Braun. „AB1188 SARS-CoV-2 VACCINATION WILLINGNESS AND PREDICTORS IN PATIENTS WITH CHRONIC INFLAMMATORY RHEUMATIC DISEASES (CIRD) AND WITHOUT CIRD“. Annals of the Rheumatic Diseases 81, Suppl 1 (23.05.2022): 1709.1–1709. http://dx.doi.org/10.1136/annrheumdis-2022-eular.5261.
Der volle Inhalt der QuelleSeymour, John F., Chan Yoon Cheah, Ricardo Parrondo, Meghan C. Thompson, Don A. Stevens, Masa Lasica, Michael L. Wang et al. „First Results from a Phase 1, First-in-Human Study of the Bruton's Tyrosine Kinase (BTK) Degrader Bgb-16673 in Patients (Pts) with Relapsed or Refractory (R/R) B-Cell Malignancies (BGB-16673-101)“. Blood 142, Supplement 1 (28.11.2023): 4401. http://dx.doi.org/10.1182/blood-2023-180109.
Der volle Inhalt der QuelleCall, Justin, Muralidhar Beeram, Alexander I. Spira, Mark Bray, Dih-Yih Chen, Long Kwei, Emily Roberts-Thomson, Trisha Denny, Roger Sidhu und Robert Wesolowski. „Abstract PO2-04-13: TWT-203: PHASE 1b/2 STUDY OF CFI-402257 AS MONOTHERAPY IN ADVANCED SOLID TUMORS AND IN COMBINATION WITH FULVESTRANT IN PATIENTS WITH ER+/HER2- ADVANCED BREAST CANCER AFTER PROGRESSION ON PRIOR CDK4/6 INHIBITORS AND ENDOCRINE THERAPY“. Cancer Research 84, Nr. 9_Supplement (02.05.2024): PO2–04–13—PO2–04–13. http://dx.doi.org/10.1158/1538-7445.sabcs23-po2-04-13.
Der volle Inhalt der QuelleBaliakas, Panagiotis, Theodoros Moysiadis, Anastasia Hadzidimitriou, Aliki Xochelli, Mattias Mattsson, Lesley-Ann Sutton, Eva Minga et al. „Tailored Approaches for Refined Prognostication in Chronic Lymphocytic Leukemia Patients with Mutated Versus Unmutated Immunoglobulin Receptors“. Blood 128, Nr. 22 (02.12.2016): 3199. http://dx.doi.org/10.1182/blood.v128.22.3199.3199.
Der volle Inhalt der QuelleGeorge III, Qiuhong Zhao, Timothy Voorhees, Nathan Denlinger, Narendranath Epperla, Audrey M. Sigmund, Gabriela Sanchez-Petitto et al. „Association between post-CART terminal complement complex (TCC) levels and clinically significant immune effector cell–associated neurotoxicity syndrome (ICANS).“ Journal of Clinical Oncology 42, Nr. 16_suppl (01.06.2024): 7036. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.7036.
Der volle Inhalt der QuelleFarooq, Umar, Matthew J. Maurer, Stephen M. Ansell, Tasha Lin, Grzegorz S. Nowakowski, Luis Porrata, David J. Inwards et al. „Treatment Patterns and Outcomes of DLBCL after Failure of Front-Line Immunochemotherapy“. Blood 126, Nr. 23 (03.12.2015): 2683. http://dx.doi.org/10.1182/blood.v126.23.2683.2683.
Der volle Inhalt der QuelleRetiere, Christelle, Catherine Willem, Thierry Guillaume, Henri Vié, Laetitia Gautrot-Rolland, Emmanuel Scotet, Xavier Saulquin et al. „Post-Transplant Cyclophosphamide (PTCY) Vs Anti-Thymoglobulin (ATG) As Part of the Gvhd Prophylaxis for Fludarabine/Clofarabine/Busulfan Reduced Intensity Conditioning (RIC) in Allogeneic Stem Cell Transplantation (allo-SCT): Influence on Early Immune Reconstitution“. Blood 126, Nr. 23 (03.12.2015): 1955. http://dx.doi.org/10.1182/blood.v126.23.1955.1955.
Der volle Inhalt der QuelleSong, Alexander, Ron Ng, John Heller, Robin Petro, Ralph D’Agostino, Thomas Lycan und Mercedes Porosnicu. „251 Factors evaluated as predictors of exceptional response to PD-1 inhibitors in patients with head and neck squamous cell cancer“. Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A272. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0251.
Der volle Inhalt der QuelleSwic, Sebastian J., Alexander G. T. MacPhail, Chinmay B. Dalal, Steven J. T. Huang, Alina S. Gerrie, Thomas J. Nevill, Heather J. Sutherland et al. „Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database“. Blood 124, Nr. 21 (06.12.2014): 2549. http://dx.doi.org/10.1182/blood.v124.21.2549.2549.
Der volle Inhalt der QuelleDonato, Eva Ma, Rafa Andreu, Aurelio Lopez, Ana Vicente, Ana Carral, Isidro Jarque, M. Angeles Ruiz et al. „A Retrospective Population-Based Study of a Series of 307 Treatment-naïve Patients with Chronic Lymphocytic Leukemia (CLL): Study of the Clinical Features and Efficacy of First-Line Therapy“. Blood 116, Nr. 21 (19.11.2010): 2452. http://dx.doi.org/10.1182/blood.v116.21.2452.2452.
Der volle Inhalt der QuelleAljawai, Yosra, Serena McDiarmid, Joseph Cappuccio, Federico Campigotto, Steven Peter Treon, Edie A. Weller, Brenda M. Birmann und Irene M. Ghobrial. „A Case-Control Epidemiological Study Of Waldenstrom Macroglobulinemia“. Blood 122, Nr. 21 (15.11.2013): 1713. http://dx.doi.org/10.1182/blood.v122.21.1713.1713.
Der volle Inhalt der QuelleMurillo, Ilda, Marcio M. Andrade, Anel Montes, Jose M. Grasa und Pilar Giraldo. „Are IgM Hevylite® Immunoglobulin Heavy Chain/Light Chain Analysis a Useful Tool to Differentiate IgM MGUS From Waldenström Macroglobulinemia?“ Blood 120, Nr. 21 (16.11.2012): 5097. http://dx.doi.org/10.1182/blood.v120.21.5097.5097.
Der volle Inhalt der QuelleNarayanan, Bhagavathi A., Cronstein Bruce, Mediero Aranzazu, und Amitabha Mazumder. „Differential Activity of Brain Derived Neurotrophic Factor (BDNF) and RANKL in Promoting Osteoclast Activity in Multiple Myeloma Patients with or without Bone Disease“. Blood 124, Nr. 21 (06.12.2014): 2058. http://dx.doi.org/10.1182/blood.v124.21.2058.2058.
Der volle Inhalt der QuelleIonescu, Filip, Nwabundo Anusim, Eva Ma, Lihua Qu, Leann Blankenship, Michael Stender und Ishmael Jaiyesimi. „Inferior Vena Cava Filter Retrieval Trends: A Single Center Experience“. Blood 134, Supplement_1 (13.11.2019): 4690. http://dx.doi.org/10.1182/blood-2019-129366.
Der volle Inhalt der QuelleWang, Wenrui. „The Ways that Digital Technologies Inform Visitor's Engagement with Cultural Heritage Sites: Informal Learning in the Digital Era“. GATR Global Journal of Business Social Sciences Review 10, Nr. 4 (30.12.2022): 237–48. http://dx.doi.org/10.35609/gjbssr.2022.10.4(3).
Der volle Inhalt der QuelleKumar, Priya, Todd E. Defor, Claudio Brunstein, Juliet Barker, John E. Wagner, Daniel J. Weisdorf, Jeffrey S. Miller et al. „Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Treatment of Acute Lymphocytic Leukemia (ALL) in 126 Adults: Impact of Donor Source on Leukemia Free Survival (LFS).“ Blood 106, Nr. 11 (16.11.2005): 2064. http://dx.doi.org/10.1182/blood.v106.11.2064.2064.
Der volle Inhalt der QuelleMorel, J., L. Dagna, B. Joven-Ibáñez, T. Holzkaemper, C. El Baou, L. Unger, A. Semeraro, N. Gullick und T. Treuer. „AB0899 A 24-month Prospective Psoriatic Arthritis Observational Study of Persistence of Treatment (PRO-SPIRIT) - Interim Analysis of Baseline Characteristics“. Annals of the Rheumatic Diseases 81, Suppl 1 (23.05.2022): 1578.1–1578. http://dx.doi.org/10.1136/annrheumdis-2022-eular.1984.
Der volle Inhalt der QuelleDewi, Melina Surya, und Yufiarti. „Play-based Learning Activities for Creativity in Children's Dance Movements“. JPUD - Jurnal Pendidikan Usia Dini 15, Nr. 1 (30.04.2021): 101–20. http://dx.doi.org/10.21009/jpud.151.06.
Der volle Inhalt der QuelleCortivo, Liliane Dal, Mathilde Bahuaud, Marie Noelle Lacassagne, Vincent Monchois, Cecile Ducasse und Marina Cavazzana-Calvo. „Anti CMV Immunotherapy with Donor Antigen Specific Lymphocytes Selected with GMP HLA Class 1 Tetramer Reagents.“ Blood 114, Nr. 22 (20.11.2009): 4492. http://dx.doi.org/10.1182/blood.v114.22.4492.4492.
Der volle Inhalt der QuelleSehn, Laurie H., Angela Giovanna Congiu, Dominic J. Culligan, Mercedes Gironella, Dok Hyun Yoon, Michinori Ogura, Andras Rosta et al. „No Added Benefit of Eight Versus Six Cycles of CHOP When Combined with Rituximab in Previously Untreated Diffuse Large B-Cell Lymphoma Patients: Results from the International Phase III GOYA Study“. Blood 132, Supplement 1 (29.11.2018): 783. http://dx.doi.org/10.1182/blood-2018-99-116845.
Der volle Inhalt der QuelleBurns, David, Katherine Clesham, Joanna Haughton, Michelle Lannon, Hayder Hussein, Jennifer Marsh, Martin Rowe et al. „Outcomes With Rituximab Monotherapy Versus R-CHOP In Post-Transplant Lymphoproliferative Disease Arising After Solid Organ Transplant: A Multicentre UK Study“. Blood 122, Nr. 21 (15.11.2013): 3043. http://dx.doi.org/10.1182/blood.v122.21.3043.3043.
Der volle Inhalt der QuelleAbaza, Yasmin, Hagop M. Kantarjian, Gautam Borthakur, Guillermo Garcia-Manero, Naval Daver, Farhad Ravandi, Srdan Verstovsek et al. „An Open-Label, Phase I Study of Dasatinib in Combination with Decitabine in Patients (Pts) with Accelerated or Blastic Phase Chronic Myeloid Leukemia (CML)“. Blood 128, Nr. 22 (02.12.2016): 5433. http://dx.doi.org/10.1182/blood.v128.22.5433.5433.
Der volle Inhalt der QuellePieri, Lisa, Giada Rotunno, Francesca Gesullo, Tiziana Fanelli, Giuditta Corbizi Fattori, Annalisa Pacilli, Federica Scarfì et al. „Prognotic Impact of Mutations in Systemic Mastocytosis“. Blood 128, Nr. 22 (02.12.2016): 1953. http://dx.doi.org/10.1182/blood.v128.22.1953.1953.
Der volle Inhalt der QuelleM, Luis Villela, Ana Ramirez-Ibarguen, Brady E. Beltrán, Victoria Otero, Denisse A. Castro, Myrna Candelaria, Fernando Pérez-Jacobo et al. „Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival“. Blood 134, Supplement_1 (13.11.2019): 1613. http://dx.doi.org/10.1182/blood-2019-123841.
Der volle Inhalt der QuelleFix, Samantha, Marie-Andrée Forget, Donastas Sakellariou-Thompson, Yunfei Wang, Ana Lucía Dominguez, Rafet Basar, Christopher Reyes et al. „172 Overcoming immunosuppressive TGF-β signaling in human ovarian cancer-derived tumor infiltrating lymphocytes via non-viral CRISPR engineering“. Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A183—A184. http://dx.doi.org/10.1136/jitc-2021-sitc2021.172.
Der volle Inhalt der QuelleCorcione, Silvia, Cecilia Grosso, Ernesta Audisio, Jessica Cusato, Miriam Antonucci, Alessandro Busca, Benedetto Bruno, Annamaria Gulla, Antonio d'Avolio und francesco Giuseppe de Rosa. „Pharmacogenetics and Pharmacokinetics of Posaconazole in Patients with Acute Myeloid Leukemia: Useful Tools for Antifungal Stewardship“. Blood 142, Supplement 1 (28.11.2023): 5849. http://dx.doi.org/10.1182/blood-2023-190034.
Der volle Inhalt der QuelleBishton, Mark, Pier Luigi Zinzani, Scott Marshall, Veronica Conteh, Alicia Rodríguez Fernández, SooKyoung Kim und Young Nam Lee. „Rapid Infusion with CT-P10 in Patients with Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukaemia: Interim Six Month Follow-up from a European Non-Interventional Post-Authorisation Safety Study“. Blood 134, Supplement_1 (13.11.2019): 4135. http://dx.doi.org/10.1182/blood-2019-121957.
Der volle Inhalt der QuelleNovi Sekar Sari, Ririn Tri Ratnasari, Ismah Osman und Ega Rusanti. „Materialism and Environmental Knowledge as a Mediator for Relationships between Religiosity and Ethical Consumption“. Jurnal Ekonomi Syariah Teori dan Terapan 10, Nr. 5 (30.09.2023): 467–81. http://dx.doi.org/10.20473/vol10iss20235pp467-481.
Der volle Inhalt der QuelleMacMillan, Margaret L., Marie Robin, Andrew C. Harris, Todd E. Defor, Paul J. Martin, Amin Alousi, Vincent T. Ho et al. „A Refined Clinical Risk Score at Onset of Treatment for Acute Gvhd That Predicts Response to Initial Therapy, Survival and Transplant-Related Mortality“. Blood 124, Nr. 21 (06.12.2014): 188. http://dx.doi.org/10.1182/blood.v124.21.188.188.
Der volle Inhalt der QuelleWang, Michael, Javier Munoz, Andre H. Goy, Frederick L. Locke, Caron A. Jacobson, Brian T. Hill, John M. Timmerman et al. „One-Year Follow-up of ZUMA-2, the Multicenter, Registrational Study of KTE-X19 in Patients with Relapsed/Refractory Mantle Cell Lymphoma“. Blood 136, Supplement 1 (05.11.2020): 20–22. http://dx.doi.org/10.1182/blood-2020-136382.
Der volle Inhalt der QuelleWarmansyah, Jhoni, Elis Komalasari, Eliza Febriani, Gusmiati und Amalina. „Factors Affecting Teacher Readiness for Online Learning (TROL) in Early Childhood Education: TISE and TPACK“. JPUD - Jurnal Pendidikan Usia Dini 16, Nr. 1 (30.04.2022): 32–51. http://dx.doi.org/10.21009/jpud.161.03.
Der volle Inhalt der QuelleKohls-Santos, Pricila, und Marília Costa Morosini. „Trilha para internacionalização em casa: Brasil-Colômbia em espaços não formais (Trail to internationalization at home: Brazil-Colombia in non-formal spaces)“. Revista Eletrônica de Educação 15 (30.11.2021): e4884048. http://dx.doi.org/10.14244/198271994884.
Der volle Inhalt der QuelleImber, Brandon S., Miguel-Angel Perales, Jessica Flynn, Josel D. Ruiz, Sean Devlin, Ana Alarcon Tomas, Carla Hajj et al. „Clinical Impact of Bridging Therapy Prior to Commercial Chimeric Antigen Receptor (CAR) T-Cell Therapies for Relapsed/Refractory Lymphomas“. Blood 136, Supplement 1 (05.11.2020): 1–2. http://dx.doi.org/10.1182/blood-2020-140991.
Der volle Inhalt der Quelle